MedTrace Logo

The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis

NCT06012084 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2025-06-04

No results posted yet for this study

Summary

The goal of the clinical trial is to test whether a mental health program that is delivered through the Internet works well for healthy children and adolescents with siblings with cystic fibrosis (CF). The main questions it aims to answer are:

* Does the program improve the mental health and quality of life of healthy siblings?
* Does the program improve the relationship between healthy children and adolescents and their sibling with CF?
* Does the program help healthy siblings learn about CF?

Participants will:

* Fill out an online survey asking questions about their family and mental health before the program
* Complete the online mental health program over five weeks
* Fill out a weekly question asking about their mood for 10 weeks
* Fill out an online survey asking questions about their family and mental health after the program

Healthy children and adolescents with siblings with CF will be compared against themselves. Researchers will compare participants scores before starting the program with their scores during and after completing the program. Researchers hope to develop a program that improves mental health, quality of life, sibling relationships, and knowledge about CF.

Conditions

Interventions

BEHAVIORAL

Internet-delivered Cystic Fibrosis Mental Health Prevention, Wellness, and Resource (iCF-PWR) program

The iCF-PWR program is a self-guided mental health prevention program designed for families with CF.

Sponsors & Collaborators

  • Saskatchewan Health Authority - Regina Area

    collaborator OTHER

  • Provincial Health Services Authority

    collaborator OTHER

  • University of Regina

    lead OTHER

Principal Investigators

  • Kristi D Wright, Ph.D · University of Regina

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-06
Primary Completion
2024-09-01
Completion
2024-09-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06012084 on ClinicalTrials.gov